Advertisement
GRAL vs PRE
To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GRAL is a Hold and PRE is a Buy.
Momentum Indicator for GRAL turns positive, indicating new upward trend
GRAL saw its Momentum Indicator move above the 0 level on October 26, 2026. This is an indication that the stock could be shifting in to a new upward move. Traders may want to consider buying the stock or buying call options. Tickeron's A.I.dvisor looked at 43 similar instances where the indicator turned positive. In 39 of the 43 cases, the stock moved higher in the following days. The odds of a move higher are at 90%.
Technical Analysis (Indicators)
Bullish Trend Analysis
Following a +5.52% 3-day Advance, the price is estimated to grow further. Considering data from situations where GRAL advanced for three days, in 114 of 131 cases, the price rose further within the following month. The odds of a continued upward trend are 87%.
The Aroon Indicator entered an Uptrend today. In 97 of 107 cases where GRAL Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 90%.
Bearish Trend Analysis
The 10-day RSI Indicator for GRAL moved out of overbought territory on October 30, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 22 similar instances where the indicator moved out of overbought territory. In 19 of the 22 cases, the stock moved lower in the following days. This puts the odds of a move lower at 86%.
The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In 25 of 30 cases where GRAL's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are 83%.
The Moving Average Convergence Divergence Histogram (MACD) for GRAL turned negative on November 02, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 20 similar instances when the indicator turned negative. In 16 of the 20 cases the stock turned lower in the days that followed. This puts the odds of success at 80%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where GRAL declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 77%.
GRAL broke above its upper Bollinger Band on October 27, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
Fundamental Analysis (Ratings)
The Tickeron Price Growth Rating for this company is 35 (best 1 - 100 worst), indicating steady price growth. GRAL’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Valuation Rating of 45 (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (2.450) is normal, around the industry mean (65.986). P/E Ratio (-14.390) is within average values for comparable stocks, (3.066). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (3.473). Dividend Yield (0.000) settles around the average of (0.002) among similar stocks. P/S Ratio (18.248) is also within normal values, averaging (9.775).
The Tickeron SMR rating for this company is 94 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron PE Growth Rating for this company is 97 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. GRAL’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 85, placing this stock worse than average.
PRE in +2.98% Uptrend, advancing for three consecutive days on October 29, 2026
Moving higher for three straight days is viewed as a bullish sign. Keep an eye on this stock for future growth. Considering data from situations where PRE advanced for three days, in 173 of 209 cases, the price rose further within the following month. The odds of a continued upward trend are 83%.
Technical Analysis (Indicators)
Bullish Trend Analysis
The RSI Indicator entered the oversold zone -- be on the watch for PRE's price rising or consolidating in the future. That's also the time to consider buying the stock or exploring call options.
The Stochastic Oscillator is in the oversold zone. Keep an eye out for a move up in the foreseeable future.
PRE may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
Bearish Trend Analysis
The Momentum Indicator moved below the 0 level on October 01, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on PRE as a result. In 89 of 112 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 79%.
PRE moved below its 50-day moving average on October 08, 2026 date and that indicates a change from an upward trend to a downward trend.
The 10-day moving average for PRE crossed bearishly below the 50-day moving average on October 08, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In 16 of 20 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are 80%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where PRE declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 88%.
The Aroon Indicator for PRE entered a downward trend on November 03, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
Fundamental Analysis (Ratings)
The Tickeron PE Growth Rating for this company is 21 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Valuation Rating of 34 (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (2.921) is normal, around the industry mean (6.194). P/E Ratio (-5.762) is within average values for comparable stocks, (7.022). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (8.458). Dividend Yield (0.000) settles around the average of (0.048) among similar stocks. P/S Ratio (2.278) is also within normal values, averaging (5.003).
The Tickeron Price Growth Rating for this company is 61 (best 1 - 100 worst), indicating steady price growth. PRE’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron SMR rating for this company is 97 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. PRE’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 93, placing this stock worse than average.
| GRAL | PRE | |
|---|---|---|
| RSI ODDS (%) | 1 day ago 86% | 1 day ago 69% |
| Stochastic ODDS (%) | 1 day ago 83% | 1 day ago 72% |
| Momentum ODDS (%) | 1 day ago 90% | 3 days ago 79% |
| MACD ODDS (%) | 1 day ago 80% | N/A |
| TrendWeek ODDS (%) | 1 day ago 78% | 1 day ago 84% |
| TrendMonth ODDS (%) | 1 day ago 77% | 1 day ago 86% |
| Advances ODDS (%) | 7 days ago 87% | 7 days ago 83% |
| Declines ODDS (%) | 3 days ago 77% | 1 day ago 88% |
| BollingerBands ODDS (%) | 1 day ago 77% | 1 day ago 77% |
| Aroon ODDS (%) | 1 day ago 90% | 1 day ago 88% |
Long-Term Analysis
It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
GRAL’s FA Score shows that 0 FA rating(s) are green while PRE’s FA Score has 1 green FA rating(s).
- GRAL’s FA Score: 0 green, 5 red.
- PRE’s FA Score: 1 green, 4 red.
Short-Term Analysis
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
GRAL’s TA Score shows that 3 TA indicator(s) are bullish while PRE’s TA Score has 4 bullish TA indicator(s).
- GRAL’s TA Score: 3 bullish, 5 bearish.
- PRE’s TA Score: 4 bullish, 5 bearish.
Price Growth
GRAL (@Medical Specialties) experienced а -7.42% price change this week, while PRE (@Food: Major Diversified) price change was -12.15% for the same time period.
The average weekly price growth across all stocks in the @Medical Specialties industry was -2.30%. For the same industry, the average monthly price growth was -5.24%, and the average quarterly price growth was +42.12%.
The average weekly price growth across all stocks in the @Food: Major Diversified industry was -2.01%. For the same industry, the average monthly price growth was -6.31%, and the average quarterly price growth was -19.24%.
Reported Earning Dates
GRAL is expected to report earnings on Nov 04, 2026.
PRE is expected to report earnings on Nov 09, 2026.
Industries' Descriptions
@Medical Specialties (-2.30% weekly)Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.
@Food: Major Diversified (-2.01% weekly)Companies in this industry usually make a diverse range of agricultural and/or processed food. Some prominent names in this segment are Mondelez International, which makes chocolates, biscuits, cookies etc. The Kraft Heinz Company specializes in ketchups, sauces, fruit drink pouches and many more. General Mills, Inc. sells flour and cereal. Kellogg is famous for its snacks and breakfast cereal. And so on down the line. As more and more consumers are looking for healthier options in food in recent years, several legacy food companies have responded by revamping brands to include organic and no-added-sugar versions, and/or acquiring healthy food firms, and even streamlining operations.
Advertisement
GRAL and
Correlation & Price change
A.I.dvisor indicates that over the last year, GRAL has been loosely correlated with PSNL. These tickers have moved in lockstep 51% of the time. This A.I.-generated data suggests there is some statistical probability that if GRAL jumps, then PSNL could also see price increases.
| Ticker / NAME | Correlation To GRAL | 1D Price Change % | ||
|---|---|---|---|---|
| GRAL | 100% | +4.25% | ||
| PSNL - GRAL | 51% Loosely correlated | -0.06% | ||
| ADPT - GRAL | 47% Loosely correlated | +2.95% | ||
| TWST - GRAL | 44% Loosely correlated | +8.73% | ||
| GH - GRAL | 44% Loosely correlated | +2.50% | ||
| NTRA - GRAL | 41% Loosely correlated | +2.56% | ||
More | ||||
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| TEKY | 40.49 | 0.35 | +0.88% |
| Lazard Next Gen Technologies ETF (TEKY) | |||
| GRNB | 23.36 | -0.01 | -0.04% |
| VanEck Green Bond ETF (GRNB) | |||
| SPIB | 32.51 | -0.02 | -0.06% |
| State Street SPDR Portfolio Intermediate Term Corporate Bond ETF (SPIB) | |||
| JPAN | 41.40 | -0.07 | -0.18% |
| Matthews Japan Active ETF (JPAN) | |||
| SMRI | 46.83 | -0.30 | -0.63% |
| Bushido Capital US Equity ETF (SMRI) | |||